2025-03-09 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis

This report analyzes Colgate-Palmolive Co (CL), a leading manufacturer of consumer products, focusing on its recent performance and future prospects.


**1) Performance Comparison & Alpha/Beta Analysis:**

Colgate-Palmolive's cumulative return (48.01%) significantly underperformed the S&P 500 (VOO) with a cumulative return of 108.62%.  The difference is -60.6%, placing it in the 29.9th percentile of its historical range of underperformance (-90% to +8.2%). This indicates consistent underperformance relative to the broader market.

The provided Alpha/Beta analysis reveals mixed results.  While Alpha (excess return relative to the market) is positive in several periods, indicating periods of outperformance, it's inconsistent and often accompanied by high Maximum Drawdowns (MDD).  Beta, representing market sensitivity, is consistently around 0.5-1.0, showing a relatively moderate correlation with the market.  The market cap shows consistent growth over the period.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 4.6% | -15.0% | 0.1 | 51.5 |
| 2016-2018  | -12.0% | 8.5% | -30.0% | 0.3 | 41.6 |
| 2017-2019  | 9.0% | 8.5% | -21.0% | 0.2 | 49.4 |
| 2018-2020  | 21.0% | 8.5% | -6.0% | 0.7 | 62.8 |
| 2019-2021  | 32.0% | 7.3% | -39.0% | 1.0 | 64.1 |
| 2020-2022  | 7.0% | 9.3% | -2.0% | 1.0 | 60.6 |
| 2021-2023  | 3.0% | 9.3% | -20.0% | 1.0 | 62.9 |
| 2022-2024  | 13.0% | 9.3% | -10.0 | 1.0 | 73.4 |
| 2023-2025  | 33.0% | 8.8% | 0.5 | 0.7 | 78.5 |


**2) Recent Price Movement:**

* **Closing Price:** $96.74
* **Daily Change:** +$3.70 (3.96%) – Significant upward movement.
* **5-Day Moving Average:** $93.13
* **20-Day Moving Average:** $89.57
* **60-Day Moving Average:** $89.56

The price is above all moving averages, suggesting a recent upward trend.  The significant daily increase warrants further investigation for potential triggers.


**3) Technical Indicators & Expected Return:**

* **RSI (79.01):**  Indicates the stock is in overbought territory, suggesting potential for a near-term correction.
* **PPO (0.81):** Positive value suggests a bullish momentum.
* **20-Day Relative Divergence Change (+15.9):**  Points to a recent sharp increase in relative strength.

The recent price increase (3.70) combined with high RSI suggests potential short-term volatility. The expected return of -103.6% relative to the S&P 500 over the long term (2+ years) is highly negative, indicating significant underperformance is anticipated.


**4) Recent Earnings Analysis:**

The earnings data shows relatively stable revenue around $5 billion, with slight fluctuations. EPS shows modest growth.  Further analysis is needed to understand the drivers of this relatively consistent performance.

| 날짜       | EPS | 매출          |
|------------|-----|---------------|
| 2024-10-25 | 0.9 | 5.03 B$       |
| 2024-07-26 | 0.89 | 5.06 B$       |
| 2024-04-26 | 0.83 | 5.07 B$       |
| 2023-10-27 | 0.86 | 4.92 B$       |
| 2024-10-25 | 0.86 | 4.92 B$       |


**5) Financial Information:**

Revenue remains consistently high around $5 billion. Profit margins are strong and stable, hovering around 60%.  However, Equity and ROE show significant volatility, requiring deeper investigation into potential underlying factors. The high ROE values are particularly noteworthy and may warrant further scrutiny for sustainability.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30% |
| 2024-09-30 | $5.03B | 61.08% |
| 2024-06-30 | $5.06B | 60.62% |
| 2024-03-31 | $5.07B | 60.00% |
| 2023-12-31 | $4.95B | 59.60% |


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $0.21B | 348.58% |
| 2024-09-30 | $0.43B | 169.43% |
| 2024-06-30 | $0.12B | 594.31% |
| 2024-03-31 | $0.23B | 296.96% |
| 2023-12-31 | $0.61B | 117.90% |


**6) Overall Conclusion:**

Colgate-Palmolive demonstrates consistent revenue and strong profit margins. However, its stock performance significantly lags the S&P 500,  a trend highlighted by negative alpha values over various periods. The recent price surge, while positive, needs careful monitoring given the overbought RSI.  High ROE figures warrant further investigation for underlying causes and long-term sustainability.  The predicted long-term underperformance relative to the market (-103.6% expected return) is a serious concern for long-term investors.  Further analysis into the causes of this underperformance, including competitive pressures, market sentiment, and company-specific factors is crucial before making any investment decisions.
